Distinct localizations and roles of non-muscle myosin II during proplatelet formation and platelet release

被引:15
作者
Badirou, I. [1 ,2 ,3 ]
Pan, J. [1 ,2 ,3 ]
Souquere, S. [2 ,3 ,4 ]
Legrand, C. [1 ,2 ,3 ]
Pierron, G. [2 ,3 ,4 ]
Wang, A. [5 ]
Eckly, A. [1 ,6 ,7 ,8 ]
Roy, A. [1 ,2 ,3 ]
Gachet, C. [1 ,6 ,7 ,8 ]
Vainchenker, W. [1 ,2 ,3 ]
Chang, Y. [1 ,2 ,3 ]
Leon, C. [1 ,6 ,7 ,8 ]
机构
[1] INSERM, Villejuif, France
[2] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France
[3] Inst Gustave Roussy, Villejuif, France
[4] CNRS, Villejuif, France
[5] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA
[6] Etab Francais Sang Alsace, Strasbourg, France
[7] Univ Strasbourg, Fac Med, Strasbourg, France
[8] Federat Med Translat, Strasbourg, France
关键词
megakaryocyte; Non-muscle myosin type IIA; Non-muscle myosin type IIB; platelet; stem cell; RESTRICTED MYH9 INACTIVATION; CONTRACTILE RING; ISOFORM; MICE; POLYPLOIDIZATION; INHIBITION; EXPRESSION; DEFECTS; RUNX1; TAIL;
D O I
10.1111/jth.12887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAt the end of maturation, megakaryocytes (MKs) form long cytoplasmic extensions called proplatelets (PPT). Enormous changes in cytoskeletal structures cause PPT to extend further, to re-localize organelles such as mitochondria and to fragment, leading to platelet release. Two non-muscle myosin IIs (NMIIs) are expressed in MKs; however, only NMII-A (MYH9), but not NMII-B (MYH10), is expressed in mature MKs and is implicated in PPT formation. ObjectivesTo provide invivo evidence on the specific role of NMII-A and IIB in MK PPT formation. MethodsWe studied two transgenic mouse models in which non-muscle myosin heavy chain (NMHC) II-A was genetically replaced either by II-B or by a chimeric NMHCII that combined the head domain of II-A with the rod and tail domains of II-B. Results and ConclusionsThis work demonstrates that the kinetic properties of NM-IIA, depending on the N-terminal domain, render NMII-A the better NMII candidate to control PPT formation. Furthermore, the carboxyl-terminal domain determines myosin II localization in the constriction region of PPT and is responsible for the specific role of NMII in platelet release.
引用
收藏
页码:851 / 859
页数:9
相关论文
共 19 条
[1]   MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations [J].
Antony-Debre, Ileana ;
Bluteau, Dominique ;
Itzykson, Raphael ;
Baccini, Veronique ;
Renneville, Aline ;
Boehlen, Francoise ;
Morabito, Margot ;
Droin, Nathalie ;
Deswarte, Caroline ;
Chang, Yunhua ;
Leverger, Guy ;
Solary, Eric ;
Vainchenker, William ;
Favier, Remi ;
Raslova, Hana .
BLOOD, 2012, 120 (13) :2719-2722
[2]   Carboxyl-terminal-dependent recruitment of nonmuscle myosin II to megakaryocyte contractile ring during polyploidization [J].
Badirou, Idinath ;
Pan, Jiajia ;
Legrand, Celine ;
Wang, Aibing ;
Lordier, Larissa ;
Boukour, Siham ;
Roy, Anita ;
Vainchenker, William ;
Chang, Yunhua .
BLOOD, 2014, 124 (16) :2564-2568
[3]   Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias [J].
Balduini, Carlo L. ;
Pecci, Alessandro ;
Savoia, Anna .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (02) :161-174
[4]   Replacement of nonmuscle myosin II-B with II-A rescues brain but not cardiac defects in mice [J].
Bao, Jianjun ;
Ma, Xuefei ;
Liu, Chengyu ;
Adelstein, Robert S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (30) :22102-22111
[5]   Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression [J].
Bluteau, Dominique ;
Glembotsky, Ana C. ;
Raimbault, Anna ;
Balayn, Nathalie ;
Gilles, Laure ;
Rameau, Philippe ;
Nurden, Paquita ;
Alessi, Marie Christine ;
Debili, Najet ;
Vainchenker, William ;
Heller, Paula G. ;
Favier, Remi ;
Raslova, Hana .
BLOOD, 2012, 120 (13) :2708-2718
[6]   Proplatelet formation is regulated by the Rho/ROCK pathway [J].
Chang, Yunhua ;
Aurade, Frederic ;
Larbret, Frederic ;
Zhang, Yanyan ;
Le Couedic, Jean-Pierre ;
Momeux, Laurence ;
Larghero, Jerome ;
Bertoglio, Jacques ;
Louache, Fawzia ;
Cramer, Elisabeth ;
Vainchenker, William ;
Debili, Najet .
BLOOD, 2007, 109 (10) :4229-4236
[7]   The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition [J].
Chen, Y. ;
Boukour, S. ;
Milloud, R. ;
Favier, R. ;
Saposnik, B. ;
Schlegel, N. ;
Nurden, A. ;
Raslova, H. ;
Vainchenker, W. ;
Balland, M. ;
Nurden, P. ;
Debili, N. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (12) :2163-2175
[8]   Regulation of platelet biogenesis: insights from the May-Hegglin anomaly and other MYH9-related disorders [J].
Chen, Z. ;
Shivdasani, R. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 :272-276
[9]   Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice [J].
Eckly, A. ;
Rinckel, J. -Y. ;
Laeuffer, P. ;
Cazenave, J. -P. ;
Lanza, F. ;
Gachet, C. ;
Leon, C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (10) :2243-2251
[10]   Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation [J].
Eckly, Anita ;
Strassel, Catherine ;
Freund, Monique ;
Cazenave, Jean-Pierre ;
Lanza, Francois ;
Gachet, Christian ;
Leon, Catherine .
BLOOD, 2009, 113 (14) :3182-3189